Adli Law Litigation Team Heads to Trial for TEK Corporation
This week Dr. Adli is leading the Adli Law Group litigation team in a patent trial in Federal Court in...
Patent Jury Trials
Patent claimants, or patentees, fare better than alleged patent infringers with juries than they do with...
Avoid Legal Troubles As a Small Business Owner
Dr. Adli will be on the air with Austin Hill for “Austin Hill’s Big World of Small Business”...
What is the purpose of your company? Put all the details in your business plan
The first step we discuss with our clients is making sure that they have an effective business plan....
Which business contract is the right one for you?
When first establishing a new business it’s important to identify and create the necessary business...
Submit a Topic Proposal
Want more general information about a topic? Submit your request here to have Adli Law Group, P.C. consider your blog topic request.
Global Chemical Manufacturer Turns to Adli Law Group P.C. in Patent Litigation Trial
LOS ANGELES, CALIF. (April 24, 2012) – Adli Law Group P.C., a world-class litigation, business law and intellectual property law firm, proudly represented a Japanese-based corporation last month before the International Trade Commission in Washington D.C.
On March 12, 2012, the International Trade Commission in Washington D.C. opened the hearing in Investigation No. 337-TA-772, in which Adli Law Group P.C. represented the Complainant Patent Holder in its case against a foreign manufacturer of polyimide films. At issue were dozens of products that infringe four United States Patents directed to polyimide films and their methods of manufacture. Over the course of the five day hearing, Adli Law Group’s trial team, led by Dr. Dariush Adli and Joseph Zito, presented evidence before the Honorable Judge Robert K. Rogers proving that the Complainant has a protectable interest in its patents, which are being illegally imported into the United States by the Respondents. Adli Law Group P.C. has asked the Commission to block importation of those infringing products and all “downstream” products that incorporate the infringing products. A decision is expected in early Summer 2012.